Your search returned 16 results.

Results
	1.	Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Authors' reply. [electronic resource] by Truitt, Kenneth E Anderson, Robert P Producer: 20200331 In: Alimentary pharmacology & therapeutics vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa. [electronic resource] by Parasrampuria, Dolly A Truitt, Kenneth E Producer: 20170911 In: Clinical pharmacokinetics vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from MEDLINE and EMBASE. [electronic resource] by Merante, Domenico Menchini, Francesca Truitt, Kenneth E Bandello, Francesco M Producer: 20110421 In: Drug safety vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects. [electronic resource] by Bays, Harold E Goldberg, Ronald B Truitt, Kenneth E Jones, Michael R Producer: 20081028 In: Archives of internal medicine vol. 168 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Safety and efficacy of colesevelam HCl in the treatment of elderly patients. [electronic resource] by Gavin, James R Jones, Michael R Ford, Daniel M Truitt, Kenneth E Producer: 20150106 In: Drugs & aging vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. [electronic resource] by Goldberg, Ronald B Fonseca, Vivian A Truitt, Kenneth E Jones, Michael R Producer: 20080819 In: Archives of internal medicine vol. 168 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. [electronic resource] by Fonseca, Vivian A Rosenstock, Julio Wang, Antonia C Truitt, Kenneth E Jones, Michael R Producer: 20080820 In: Diabetes care vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator. [electronic resource] by Moberly, James B Rohatagi, Shashank Zahir, Hamim Hsu, Ching Noveck, Robert J Truitt, Kenneth E Producer: 20121116 In: Journal of clinical pharmacology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator. [electronic resource] by Rohatagi, Shashank Zahir, Hamim Moberly, James B Truitt, Kenneth E Inaba, Shin-ichi Shimozato, Takaichi Carrothers, T J Producer: 20090225 In: Journal of clinical pharmacology vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	A 26-week, placebo- and pioglitazone-controlled, dose-ranging study of rivoglitazone, a novel thiazolidinedione for the treatment of type 2 diabetes. [electronic resource] by Truitt, Kenneth E Goldberg, Ronald B Rosenstock, Julio Chou, Hubert S Merante, Domenico Triscari, Joseph Wang, Antonia C Producer: 20100908 In: Current medical research and opinion vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients. [electronic resource] by Moberly, James B Ford, Daniel M Zahir, Hamim Chen, Shuquan Mochizuki, Takashi Truitt, Kenneth E Vollmer, Timothy L Producer: 20120619 In: Journal of neuroimmunology vol. 246 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease. [electronic resource] by Truitt, Kenneth E Daveson, A James M Ee, Hooi C Goel, Gautam MacDougall, James Neff, Kristin Anderson, Robert P Producer: 20200526 In: Alimentary pharmacology & therapeutics vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. [electronic resource] by Moberly, James B Xu, Jianbo Desjardins, Paul J Daniels, Stephen E Bandy, Donald P Lawson, Janet E Link, Allison J Truitt, Kenneth E Producer: 20070803 In: Clinical therapeutics vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa. [electronic resource] by Moberly, James B Harris, Stuart I Riff, Dennis S Dale, James Craig Breese, Tara McLaughlin, Patrick Lawson, Janet Wan, Yaping Xu, Jianbo Truitt, Kenneth E Producer: 20070403 In: Digestive diseases and sciences vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. [electronic resource] by Daveson, A James M Tye-Din, Jason A Goel, Gautam Goldstein, Kaela E Hand, Holly L Neff, Kristin M Williams, Leslie J Truitt, Kenneth E Anderson, Robert P Producer: 20200727 In: Alimentary pharmacology & therapeutics vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. [electronic resource] by Tye-Din, Jason A Daveson, A James M Ee, Hooi C Goel, Gautam MacDougall, James Acaster, Sarah Goldstein, Kaela E Dzuris, John L Neff, Kristin M Truitt, Kenneth E Anderson, Robert P Producer: 20200520 In: Alimentary pharmacology & therapeutics vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)